M
Marek Ancukiewicz
Researcher at Harvard University
Publications - 143
Citations - 20032
Marek Ancukiewicz is an academic researcher from Harvard University. The author has contributed to research in topics: Radiation therapy & Bevacizumab. The author has an hindex of 56, co-authored 142 publications receiving 18390 citations. Previous affiliations of Marek Ancukiewicz include University of Colorado Denver & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Evolution of oxygen and glucose concentration profiles in a tissue-mimetic culture system of embryonic stem cells.
TL;DR: A mathematical model was utilized to predict the time course of the development of oxygen and glucose concentration gradients within the tissue-mimetic culture system, and the model and the TMCS provide useful tools for investigating the effect of the metabolic microenvironment on cells in culture.
Journal ArticleDOI
Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer.
Jeffrey A. Meyerhardt,Marek Ancukiewicz,Thomas A. Abrams,Deborah Schrag,Peter C. Enzinger,Jennifer A. Chan,Matthew H. Kulke,Brian M. Wolpin,Michael Goldstein,Lawrence S. Blaszkowsky,Andrew X. Zhu,Meaghan Elliott,Eileen Regan,Rakesh K. Jain,Dan G. Duda +14 more
TL;DR: Vandetanib can be safely combined with cetuximab and irinotecan for metastatic colorectal cancer and differential effects on certain plasma biomarkers for VEGFR inhibition when combined with EGFR blockade and a potential correlation between baseline sVEGFR1 and response are suggested.
Journal ArticleDOI
Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.
Raymond H. Mak,Harvey J. Mamon,David P. Ryan,David T. Miyamoto,Marek Ancukiewicz,Wendy Kobayashi,Christopher G. Willett,Noah C. Choi,Lawrence S. Blaszkowsky,Theodore S. Hong +9 more
TL;DR: Elderly patients with esophageal cancer treated with full-dose chemoradiation from 2002 to 2008 experienced substantial morbidity from che MORadiation, and long-term survival was low.
Journal ArticleDOI
Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer
Kristina Mirabeau-Beale,Theodore S. Hong,Andrzej Niemierko,Marek Ancukiewicz,Lawrence S. Blaszkowsky,Elizabeth Crowley,James C. Cusack,Lorraine C. Drapek,Nataliya Kovalchuk,Meghan Markowski,Brian Napolitano,Jacqueline A. Nyamwanda,David P. Ryan,John A. Wolfgang,Lisa A. Kachnic,Jennifer Y. Wo +15 more
TL;DR: VS is a common late complication in women treated definitively with chemoradiation for anal canal cancer and younger age, higher tumor dose, and earlier year of treatment were associated with a higher grade of stenosis.
Journal ArticleDOI
Dye-Enhanced Multimodal Confocal Imaging as a Novel Approach to Intraoperative Diagnosis of Brain Tumors
Matija Snuderl,Dennis Wirth,Sameer A. Sheth,Sarah K. Bourne,Churl-Su Kwon,Marek Ancukiewicz,William T. Curry,Matthew P. Frosch,Anna N. Yaroslavsky,Anna N. Yaroslavsky +9 more
TL;DR: Results confirm the feasibility of multimodal confocal imaging for intravital intraoperative diagnosis and distinguish gliomas from normal brain tissue and nonglial brain tumors, and to render diagnoses from the images in a manner comparable to haematoxylin and eosin slides.